Copyright © PrEP'D For Change, 2018

  • Facebook Social Icon

Support for doctors

Thank you

PrEP’D For Change recognises and is grateful for the ongoing work of healthcare professionals in Australia. By continuing to be a world leader in HIV prevention and treatment you’re helping to protect the physical and mental wellbeing of all Australians, and we'd like to say thank you.

Map updates

PrEP'D For Change manages an interactive map for patients to locate known PrEP prescribers around Australia. If you would like to appear on the map, use our contact form to get in touch.

Overview

When used as pre-exposure prophylaxis (PrEP) against human immunodeficiency virus (HIV) infection, the medicines in PrEP are listed on the PBS General Schedule with streamlined authority required.

 

Three bioequivalent versions are TGA approved and PBS listed, containing any one of these formulations:

  • Tenofovir Disoproxil Fumarate 300mg and Emtricitabine 200mg

  • Tenofovir Disoproxil Maleate 300mg and Emtricitabine 200mg

  • Tenofovir Disoproxil Phosphate 291mg and Emtricitabine 200mg

 

A maximum quantity of one pack containing 30 pills with no more than two repeats can be prescribed. Clinical guidelines require baseline tests before starting PrEP with return follow-up and repeat tests every three months.

Clinical resources

PrEP resources for clinicians are available from the Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM).

 

Update on PrEP for HIV Clinicians — This communique is for clinicians involved in HIV, who may be consulted about HIV PrEP.

HIV pre-exposure prophylaxis: clinical guidelines. Update April 2018 — These guidelines have been published in the Journal of Virus Eradication representing an adaptation and a revision of the 2014 United States Centers for Disease Control's PrEP guidelines. The Australian PrEP Guidelines have the benefits of having been written and edited by clinicians, epidemiologists and representatives of peak Australian HIV community organisations who have significant experience of PrEP in the clinical, research and real-world settings. These guidelines are written for clinicians who will be initiating PrEP and monitoring people taking PrEP and are designed to reflect Australia’s unique epidemiology.

Decision making in PrEP — This tool provides a prescribing pathway which summarises the key eligibility and recommended assessment for primary care providers in Australia who wish to prescribe PrEP and the ongoing patient education and monitoring requirements.

PrEP online learning module — This provides guidance for general practitioners to better understand and safely prescribe PrEP.

ASHM Facebook Live Q+A Event: PrEPPING the Health Workforce — This event was recorded April 12, 2018 with:

  • Danielle Collins, HIV Nurse Practitioner at The Alfred

  • Dr Vincent Cornelisse, Sexual Health Physician at Prahran Market Clinic, Melbourne Sexual Health Centre and PhD Candidate at Monash University

  • Associate Professor Edwina Wright, Infectious Diseases Physician and clinical researcher at The Alfred, Monash University, The Burnet Institute and The Peter Doherty Institute for Infection and Immunity

  • Chris Williams, co-founder of PrEP'D For Change

Webinar: Prescribing Pre-Exposure Prophylaxis (PrEP) for HIV in General Practice — This webinar was recorded September 12, 2018

Telephone information and support — For Victoria, call 1800 889 887 or (03) 9076 2940. For New South Wales call 1800 451 624. For Western Australia, call 1800 671 130